FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma

By afschroeder • July 20, 2025

Smyth EC, Kim KM, Rha SY, Wainberg ZA, Honeycutt H, Sommermann E, Ochiai A. FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma. Cancer Treat Rev. 2025 May 26;139:102971. doi: 10.1016/j.ctrv.2025.102971. Epub ahead of print. PMID: 40680491.

Tags: biomarkers, Fgfr2b, Fibroblast growth factor receptor, Fibroblast growth receptor 2b, gastric cancer, Hematology/Oncology, Publications, targeted therapy

Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

Green-Lott AY, Wadhwa A, Bailey AV, Kwan L, Haroldsen CL, Shelton JB, Lewis MS, Beenhouwer DO, Chamie K, Rose BS, Maxwell KN, Nickols NG, Yamoah[...]

A Case of Postural Orthostatic Tachycardia Syndrome in a 20-Year-Old Female Athlete: Review of Ivabradine Guidelines

Boyapalli S, Alvarado GA, Avanthsa U, Nagi A, Manouchehri S, Testa K, Sumalbag J, Pietras RJ, Ben-Zur UM. A Case of Postural Orthostatic Tachycardia Syndrome[...]

Virtual reality-based cognitive assessment: An exploratory pilot study including patients with cancer-related cognitive impairment

Cheng JJ, Davidovics H, Jackson NJ, Wang R, Bakshian J, Sebti R, Waksman M, Naeim A. Virtual reality-based cognitive assessment: An exploratory pilot study including[...]